Advertisement

Index by author

January 01, 1992; Volume 260,Issue 1

A

  1. Ableitner, A

    1. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
      F J Ayesta, A Ableitner, M W Emmett-Oglesby, A Herz and T S Shippenberg
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 168-174;

  2. Aiyar, N

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;

  3. Ali, S F

    1. Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
      M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;

  4. Allen, R R

    1. Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
      M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;

  5. Altiere, R J

    1. Omega-conotoxin-sensitive calcium channels modulate autonomic neurotransmission in guinea pig airways.
      R J Altiere, L Diamond and D C Thompson
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 98-103;

  6. Aronson, M J

    1. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
      P D Kanof, L Handelsman, M J Aronson, R Ness, K J Cochrane and K J Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 355-363;

  7. Atkinson, J

    1. Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
      D Henrion, J M Chillon, C Capdeville-Atkinson and J Atkinson
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 1-8;

  8. Awouters, F H

    1. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
      A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 146-159;
    2. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
      A A Megens, C J Niemegeers and F H Awouters
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 160-167;

  9. Ayesta, F J

    1. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
      F J Ayesta, A Ableitner, M W Emmett-Oglesby, A Herz and T S Shippenberg
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 168-174;

B

  1. Bailey, J R

    1. Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
      M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;

  2. Bathon, J M

    1. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
      J M Bathon, D C Manning, D W Goldman, M C Towns and D Proud
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 384-392;

  3. Beinfeld, M C

    1. Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
      J S Brog and M C Beinfeld
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 343-348;

  4. Bendele, A M

    1. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
      A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;

  5. Benslay, D N

    1. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
      A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;

  6. Binder, N D

    1. Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits.
      N D Binder and J J Faber
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 294-299;

  7. Black, A

    1. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
      M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;

  8. Black, C K

    1. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
      J H Kehne, T C McCloskey, V L Taylor, C K Black, G M Fadayel and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 78-89;

  9. Brog, J S

    1. Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
      J S Brog and M C Beinfeld
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 343-348;

  10. Brooks, D P

    1. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
      A J Nichols, P F Koster, D P Brooks and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 269-274;

  11. Brown, R M

    1. Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
      M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;

  12. Bryant, S H

    1. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
      A De Luca, D Tricarico, R Wagner, S H Bryant, V Tortorella and D Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 364-368;

C

  1. Calligaro, D O

    1. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
      M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;

  2. Cameron, J S

    1. Effects of diazoxide and glyburide on ATP-sensitive K+ channels from hypertrophied ventricular myocytes.
      F Ciampolillo, D E Tung and J S Cameron
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 254-260;

  3. Capdeville-Atkinson, C

    1. Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
      D Henrion, J M Chillon, C Capdeville-Atkinson and J Atkinson
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 1-8;

  4. Carroll, M A

    1. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites.
      M A Carroll, M P Garcia, J R Falck and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 104-109;

  5. Casalotti, S O

    1. Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.
      S O Casalotti, A P Kozikowski, A Fauq, W Tückmantel and K E Krueger
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 21-28;

  6. Chan, L

    1. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
      C Jarusiripipat, L Chan, J I Shapiro and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 243-247;

  7. Chang, T

    1. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
      M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;

  8. Chern, W H

    1. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
      J E Shaffer, B J Han, W H Chern and F W Lee
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 286-293;

  9. Chillon, J M

    1. Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
      D Henrion, J M Chillon, C Capdeville-Atkinson and J Atkinson
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 1-8;

  10. Choi, O H

    1. Effects of the amphiphilic peptides melittin and mastoparan on calcium influx, phosphoinositide breakdown and arachidonic acid release in rat pheochromocytoma PC12 cells.
      O H Choi, W L Padgett and J W Daly
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 369-375;

  11. Ciampolillo, F

    1. Effects of diazoxide and glyburide on ATP-sensitive K+ channels from hypertrophied ventricular myocytes.
      F Ciampolillo, D E Tung and J S Cameron
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 254-260;

  12. Clarke, D E

    1. Evidence for a noradrenergic innervation to "atypical" beta adrenoceptors (or putative beta-3 adrenoceptors) in the ileum of guinea pig.
      D T Taneja and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 192-200;

  13. Cochrane, K J

    1. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
      P D Kanof, L Handelsman, M J Aronson, R Ness, K J Cochrane and K J Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 355-363;

  14. Codd, E E

    1. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 275-285;

  15. Cohen, R A

    1. Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers.
      C L Cowan and R A Cohen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 248-253;

  16. Compton, D R

    1. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
      D R Compton, M R Johnson, L S Melvin and B R Martin
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 201-209;

  17. Conte Camerino, D

    1. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
      A De Luca, D Tricarico, R Wagner, S H Bryant, V Tortorella and D Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 364-368;

  18. Cooley, A J

    1. Methimazole protection of rats against chemically induced kidney damage in vivo.
      P J Sausen, A A Elfarra and A J Cooley
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 393-401;

  19. Cowan, C L

    1. Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers.
      C L Cowan and R A Cohen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 248-253;

  20. Craft, R M

    1. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
      R M Craft and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 327-333;
    2. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
      R M Craft and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 334-342;

  21. Craft, T J

    1. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
      C V Jackson, J D Frank, T J Craft, J L Sundboom and G F Smith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 64-70;

  22. Crain, S M

    1. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition.
      S M Crain and K F Shen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 182-186;

D

  1. Daly, J W

    1. Effects of the amphiphilic peptides melittin and mastoparan on calcium influx, phosphoinositide breakdown and arachidonic acid release in rat pheochromocytoma PC12 cells.
      O H Choi, W L Padgett and J W Daly
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 369-375;

  2. Danhof, M

    1. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
      J W Mandema, E Tukker and M Danhof
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 36-44;

  3. De Luca, A

    1. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
      A De Luca, D Tricarico, R Wagner, S H Bryant, V Tortorella and D Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 364-368;

  4. Dewey, W L

    1. A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
      S P Welch, D L Stevens and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 117-127;

  5. Diamond, L

    1. Omega-conotoxin-sensitive calcium channels modulate autonomic neurotransmission in guinea pig airways.
      R J Altiere, L Diamond and D C Thompson
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 98-103;

  6. Di Chiara, G

    1. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
      M Morelli, S Fenu, A Pinna and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 402-408;

  7. Dong, M K

    1. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
      M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;

  8. Dwyer, T M

    1. Cromakalim effects of acetylcholine-induced changes in cytosolic calcium and tension in swine trachealis.
      C C Shieh, M F Petrini, T M Dwyer and J M Farley
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 261-268;

  9. Dykstra, L A

    1. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
      R M Craft and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 327-333;
    2. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
      R M Craft and L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 334-342;

E

  1. Edwards, R M

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;

  2. Eichberg, J

    1. Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex.
      S J Vyas, J Eichberg and M F Lokhandwala
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 134-139;

  3. Elfarra, A A

    1. Methimazole protection of rats against chemically induced kidney damage in vivo.
      P J Sausen, A A Elfarra and A J Cooley
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 393-401;

  4. Emmett-Oglesby, M W

    1. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
      F J Ayesta, A Ableitner, M W Emmett-Oglesby, A Herz and T S Shippenberg
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 168-174;

  5. Evans, W E

    1. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
      W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;

  6. Ezekiel, M

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;

F

  1. Faber, J J

    1. Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits.
      N D Binder and J J Faber
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 294-299;

  2. Fadayel, G M

    1. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
      J H Kehne, T C McCloskey, V L Taylor, C K Black, G M Fadayel and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 78-89;

  3. Falck, J R

    1. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites.
      M A Carroll, M P Garcia, J R Falck and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 104-109;

  4. Farley, J M

    1. Cromakalim effects of acetylcholine-induced changes in cytosolic calcium and tension in swine trachealis.
      C C Shieh, M F Petrini, T M Dwyer and J M Farley
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 261-268;

  5. Fauq, A

    1. Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.
      S O Casalotti, A P Kozikowski, A Fauq, W Tückmantel and K E Krueger
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 21-28;

  6. Fenu, S

    1. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
      M Morelli, S Fenu, A Pinna and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 402-408;

  7. Foreman, M M

    1. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
      M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;

  8. Foster, S

    1. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
      R W Lee, T E Raya, U Michael, S Foster, T Meeks and S Goldman
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 349-354;

  9. Frank, J D

    1. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
      C V Jackson, J D Frank, T J Craft, J L Sundboom and G F Smith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 64-70;

  10. Fretland, D J

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;

  11. Friderichs, E

    1. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 275-285;

  12. Fujimoto, K

    1. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
      T Yamada, K Fujimoto, P Tso, T Fujimoto, T S Gaginella and M B Grisham
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 313-318;

  13. Fujimoto, T

    1. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
      T Yamada, K Fujimoto, P Tso, T Fujimoto, T S Gaginella and M B Grisham
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 313-318;

  14. Fujino, K

    1. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
      M V Westfall, G M Wahler, K Fujino and R J Solaro
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 58-63;

  15. Fuller, R W

    1. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
      M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;

G

  1. Gaginella, T S

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;
    2. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
      T Yamada, K Fujimoto, P Tso, T Fujimoto, T S Gaginella and M B Grisham
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 313-318;

  2. Galligan, J J

    1. Antagonists of nitric oxide synthesis inhibit nerve-mediated relaxations of longitudinal muscle in guinea pig ileum.
      L E Osthaus and J J Galligan
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 140-145;
    2. Differential inhibition of cholinergic and noncholinergic neurogenic contractions by 5-hydroxytryptamine1A receptor agonists in guinea pig ileum.
      J J Galligan
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 306-312;

  3. Garbrecht, W L

    1. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
      M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;

  4. Garcia, M P

    1. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites.
      M A Carroll, M P Garcia, J R Falck and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 104-109;

  5. Garrone, B

    1. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
      M Raiteri, B Garrone and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 238-242;

  6. Gilbertsen, R B

    1. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
      M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;

  7. Goldman, D W

    1. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
      J M Bathon, D C Manning, D W Goldman, M C Towns and D Proud
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 384-392;

  8. Goldman, S

    1. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
      R W Lee, T E Raya, U Michael, S Foster, T Meeks and S Goldman
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 349-354;

  9. Grider, J R

    1. Receptor-coupled G proteins mediate contraction and Ca++ mobilization in isolated intestinal muscle cells.
      K S Murthy, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 90-97;

  10. Griffin, E

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;

  11. Griffiths, D A

    1. Effect of 3'-azido-3'-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles.
      D A Griffiths, S D Hall and P P Sokol
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 128-133;

  12. Grisham, M B

    1. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
      T Yamada, K Fujimoto, P Tso, T Fujimoto, T S Gaginella and M B Grisham
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 313-318;

H

  1. Hall, S D

    1. Effect of 3'-azido-3'-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles.
      D A Griffiths, S D Hall and P P Sokol
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 128-133;

  2. Han, B J

    1. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
      J E Shaffer, B J Han, W H Chern and F W Lee
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 286-293;

  3. Handelsman, L

    1. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
      P D Kanof, L Handelsman, M J Aronson, R Ness, K J Cochrane and K J Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 355-363;

  4. Henrion, D

    1. Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
      D Henrion, J M Chillon, C Capdeville-Atkinson and J Atkinson
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 1-8;

  5. Herz, A

    1. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
      F J Ayesta, A Ableitner, M W Emmett-Oglesby, A Herz and T S Shippenberg
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 168-174;

  6. Hofbauer, K

    1. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
      U Humke, N Levens, J Wood and K Hofbauer
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 29-35;

  7. Hom, J T

    1. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
      A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;

  8. Huang, K X

    1. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
      K X Huang and J R Walters
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 409-416;

  9. Humke, U

    1. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
      U Humke, N Levens, J Wood and K Hofbauer
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 29-35;

I

  1. Im, W B

    1. Block of sodium channel current by anticonvulsant U-54494A in mouse neuroblastoma cells.
      Y Zhu and W B Im
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 110-116;

J

  1. Jackson, C V

    1. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
      C V Jackson, J D Frank, T J Craft, J L Sundboom and G F Smith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 64-70;

  2. Jackson, E K

    1. In vivo evaluation of the antagonist activity of angiotensin I analogs.
      E K Jackson
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 223-231;

  3. Janssen, P A

    1. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
      A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 146-159;

  4. Jarusiripipat, C

    1. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
      C Jarusiripipat, L Chan, J I Shapiro and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 243-247;

  5. Johnson, M R

    1. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
      D R Compton, M R Johnson, L S Melvin and B R Martin
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 201-209;

K

  1. Kachur, J F

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;

  2. Kanof, P D

    1. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
      P D Kanof, L Handelsman, M J Aronson, R Ness, K J Cochrane and K J Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 355-363;

  3. Keenan, R M

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;

  4. Kehne, J H

    1. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
      J H Kehne, T C McCloskey, V L Taylor, C K Black, G M Fadayel and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 78-89;

  5. Keith, R H

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;

  6. Kocan, G

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;

  7. Koster, P F

    1. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
      A J Nichols, P F Koster, D P Brooks and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 269-274;

  8. Kozikowski, A P

    1. Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.
      S O Casalotti, A P Kozikowski, A Fauq, W Tückmantel and K E Krueger
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 21-28;

  9. Krueger, K E

    1. Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.
      S O Casalotti, A P Kozikowski, A Fauq, W Tückmantel and K E Krueger
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 21-28;

  10. Kurz, K D

    1. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
      M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;

L

  1. Lee, F W

    1. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
      J E Shaffer, B J Han, W H Chern and F W Lee
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 286-293;

  2. Lee, R W

    1. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
      R W Lee, T E Raya, U Michael, S Foster, T Meeks and S Goldman
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 349-354;

  3. Lee, S J

    1. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
      A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;

  4. Lerer, B

    1. Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.
      M E Newman, B Shapira and B Lerer
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 16-20;

  5. Levens, N

    1. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
      U Humke, N Levens, J Wood and K Hofbauer
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 29-35;

  6. Lindstrom, T D

    1. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
      A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;

  7. Lokhandwala, M F

    1. Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex.
      S J Vyas, J Eichberg and M F Lokhandwala
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 134-139;

M

  1. Makhlouf, G M

    1. Receptor-coupled G proteins mediate contraction and Ca++ mobilization in isolated intestinal muscle cells.
      K S Murthy, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 90-97;

  2. Mandema, J W

    1. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
      J W Mandema, E Tukker and M Danhof
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 36-44;

  3. Manning, D C

    1. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
      J M Bathon, D C Manning, D W Goldman, M C Towns and D Proud
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 384-392;

  4. Martin, B R

    1. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
      D R Compton, M R Johnson, L S Melvin and B R Martin
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 201-209;

  5. McCloskey, T C

    1. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
      J H Kehne, T C McCloskey, V L Taylor, C K Black, G M Fadayel and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 78-89;

  6. McGiff, J C

    1. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites.
      M A Carroll, M P Garcia, J R Falck and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 104-109;

  7. McLean, M J

    1. Use-, concentration- and voltage-dependent limitation by MK-801 of action potential firing frequency in mouse central neurons in cell culture.
      A W Wamil and M J McLean
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 376-383;

  8. Meeks, T

    1. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
      R W Lee, T E Raya, U Michael, S Foster, T Meeks and S Goldman
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 349-354;

  9. Meert, T F

    1. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
      A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 146-159;

  10. Megens, A A

    1. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
      A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 146-159;
    2. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
      A A Megens, C J Niemegeers and F H Awouters
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 160-167;

  11. Melvin, L S

    1. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.
      D R Compton, M R Johnson, L S Melvin and B R Martin
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 201-209;

  12. Michael, U

    1. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
      R W Lee, T E Raya, U Michael, S Foster, T Meeks and S Goldman
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 349-354;

  13. Misner, J W

    1. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
      M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;

  14. Morelli, M

    1. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
      M Morelli, S Fenu, A Pinna and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 402-408;

  15. Murthy, K S

    1. Receptor-coupled G proteins mediate contraction and Ca++ mobilization in isolated intestinal muscle cells.
      K S Murthy, J R Grider and G M Makhlouf
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 90-97;

N

  1. Naismith, R W

    1. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
      A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;

  2. Nelson, D L

    1. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
      M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;

  3. Ness, R

    1. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
      P D Kanof, L Handelsman, M J Aronson, R Ness, K J Cochrane and K J Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 355-363;

  4. Newman, M E

    1. Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.
      M E Newman, B Shapira and B Lerer
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 16-20;

  5. Nichols, A J

    1. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
      A J Nichols, P F Koster, D P Brooks and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 269-274;

  6. Niemegeers, C J

    1. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
      A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 146-159;
    2. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
      A A Megens, C J Niemegeers and F H Awouters
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 160-167;

O

  1. Ohlstein, E H

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;

  2. Osthaus, L E

    1. Antagonists of nitric oxide synthesis inhibit nerve-mediated relaxations of longitudinal muscle in guinea pig ileum.
      L E Osthaus and J J Galligan
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 140-145;

P

  1. Padgett, W L

    1. Effects of the amphiphilic peptides melittin and mastoparan on calcium influx, phosphoinositide breakdown and arachidonic acid release in rat pheochromocytoma PC12 cells.
      O H Choi, W L Padgett and J W Daly
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 369-375;

  2. Pang, C C

    1. The sympathetic nervous system facilitates endothelin-1 effects on venous tone.
      R P Waite and C C Pang
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 45-50;

  3. Paris, H

    1. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
      A Remaury and H Paris
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 417-426;

  4. Parli, C J

    1. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.
      M M Foreman, R W Fuller, D L Nelson, D O Calligaro, K D Kurz, J W Misner, W L Garbrecht and C J Parli
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 51-57;

  5. Paule, M G

    1. Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
      M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;

  6. Petrini, M F

    1. Cromakalim effects of acetylcholine-induced changes in cytosolic calcium and tension in swine trachealis.
      C C Shieh, M F Petrini, T M Dwyer and J M Farley
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 261-268;

  7. Petros, W P

    1. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
      W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;

  8. Pinna, A

    1. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
      M Morelli, S Fenu, A Pinna and G Di Chiara
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 402-408;

  9. Pittaluga, A

    1. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
      A Pittaluga and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 232-237;
    2. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
      M Raiteri, B Garrone and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 238-242;

  10. Proud, D

    1. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
      J M Bathon, D C Manning, D W Goldman, M C Towns and D Proud
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 384-392;

  11. Pui, C H

    1. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
      W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;

R

  1. Raffa, R B

    1. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 275-285;

  2. Raiteri, M

    1. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
      A Pittaluga and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 232-237;
    2. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
      M Raiteri, B Garrone and A Pittaluga
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 238-242;

  3. Raya, T E

    1. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
      R W Lee, T E Raya, U Michael, S Foster, T Meeks and S Goldman
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 349-354;

  4. Reimann, W

    1. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 275-285;

  5. Relling, M V

    1. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
      W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;

  6. Remaury, A

    1. The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites.
      A Remaury and H Paris
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 417-426;

  7. Rivera, G K

    1. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
      W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;

  8. Rodman, J H

    1. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
      W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;

  9. Rubinstein, K J

    1. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
      P D Kanof, L Handelsman, M J Aronson, R Ness, K J Cochrane and K J Rubinstein
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 355-363;

  10. Ruffolo, R R

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;
    2. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
      A J Nichols, P F Koster, D P Brooks and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 269-274;

  11. Ruterbories, K J

    1. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
      A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;

S

  1. Sausen, P J

    1. Methimazole protection of rats against chemically induced kidney damage in vivo.
      P J Sausen, A A Elfarra and A J Cooley
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 393-401;

  2. Scallet, A C

    1. Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
      M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;

  3. Schellekens, K H

    1. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
      A A Megens, F H Awouters, T F Meert, K H Schellekens, C J Niemegeers and P A Janssen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 146-159;

  4. Schmidt, C J

    1. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
      J H Kehne, T C McCloskey, V L Taylor, C K Black, G M Fadayel and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 78-89;

  5. Schrier, D J

    1. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
      M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;

  6. Schrier, R W

    1. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
      C Jarusiripipat, L Chan, J I Shapiro and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 243-247;

  7. Scott, M E

    1. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
      M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;

  8. Shaffer, J E

    1. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
      J E Shaffer, B J Han, W H Chern and F W Lee
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 286-293;

  9. Shank, R P

    1. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 275-285;

  10. Shapira, B

    1. Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine1A agonist and antidepressants.
      M E Newman, B Shapira and B Lerer
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 16-20;

  11. Shapiro, J I

    1. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
      C Jarusiripipat, L Chan, J I Shapiro and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 243-247;

  12. Shen, K F

    1. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition.
      S M Crain and K F Shen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 182-186;

  13. Shieh, C C

    1. Cromakalim effects of acetylcholine-induced changes in cytosolic calcium and tension in swine trachealis.
      C C Shieh, M F Petrini, T M Dwyer and J M Farley
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 261-268;

  14. Shippenberg, T S

    1. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
      F J Ayesta, A Ableitner, M W Emmett-Oglesby, A Herz and T S Shippenberg
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 168-174;

  15. Sircar, J C

    1. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
      M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;

  16. Slikker, W

    1. Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.
      M G Paule, R R Allen, J R Bailey, A C Scallet, S F Ali, R M Brown and W Slikker
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 210-222;

  17. Smith, G F

    1. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
      C V Jackson, J D Frank, T J Craft, J L Sundboom and G F Smith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 64-70;

  18. Sokol, P P

    1. Effect of 3'-azido-3'-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles.
      D A Griffiths, S D Hall and P P Sokol
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 128-133;

  19. Solaro, R J

    1. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
      M V Westfall, G M Wahler, K Fujino and R J Solaro
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 58-63;

  20. Spaethe, S M

    1. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis.
      A M Bendele, D N Benslay, J T Hom, S M Spaethe, K J Ruterbories, T D Lindstrom, S J Lee and R W Naismith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 300-305;

  21. Stevens, D L

    1. A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
      S P Welch, D L Stevens and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 117-127;

  22. Stewart, C F

    1. Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia.
      W E Evans, J H Rodman, M V Relling, W P Petros, C F Stewart, C H Pui and G K Rivera
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 71-77;

  23. Sundboom, J L

    1. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
      C V Jackson, J D Frank, T J Craft, J L Sundboom and G F Smith
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 64-70;

  24. Suto, M J

    1. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
      M K Dong, M E Scott, D J Schrier, M J Suto, J C Sircar, A Black, T Chang and R B Gilbertsen
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 319-326;

T

  1. Taneja, D T

    1. Evidence for a noradrenergic innervation to "atypical" beta adrenoceptors (or putative beta-3 adrenoceptors) in the ileum of guinea pig.
      D T Taneja and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 192-200;

  2. Taylor, V L

    1. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
      J H Kehne, T C McCloskey, V L Taylor, C K Black, G M Fadayel and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 78-89;

  3. Tejani-Butt, S M

    1. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
      S M Tejani-Butt
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 427-436;

  4. Thompson, D C

    1. Omega-conotoxin-sensitive calcium channels modulate autonomic neurotransmission in guinea pig airways.
      R J Altiere, L Diamond and D C Thompson
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 98-103;

  5. Toll, L

    1. Comparison of mu opioid receptor binding on intact neuroblastoma cells with guinea pig brain and neuroblastoma cell membranes.
      L Toll
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 9-15;

  6. Tortorella, V

    1. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
      A De Luca, D Tricarico, R Wagner, S H Bryant, V Tortorella and D Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 364-368;

  7. Towns, M C

    1. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
      J M Bathon, D C Manning, D W Goldman, M C Towns and D Proud
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 384-392;

  8. Tricarico, D

    1. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
      A De Luca, D Tricarico, R Wagner, S H Bryant, V Tortorella and D Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 364-368;

  9. Tsai, B S

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;

  10. Tso, P

    1. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
      T Yamada, K Fujimoto, P Tso, T Fujimoto, T S Gaginella and M B Grisham
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 313-318;

  11. Tückmantel, W

    1. Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.
      S O Casalotti, A P Kozikowski, A Fauq, W Tückmantel and K E Krueger
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 21-28;

  12. Tukker, E

    1. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
      J W Mandema, E Tukker and M Danhof
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 36-44;

  13. Tung, D E

    1. Effects of diazoxide and glyburide on ATP-sensitive K+ channels from hypertrophied ventricular myocytes.
      F Ciampolillo, D E Tung and J S Cameron
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 254-260;

V

  1. Vaught, J L

    1. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
      R B Raffa, E Friderichs, W Reimann, R P Shank, E E Codd and J L Vaught
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 275-285;

  2. Villani-Price, D

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;

  3. Vyas, S J

    1. Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex.
      S J Vyas, J Eichberg and M F Lokhandwala
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 134-139;

W

  1. Wagner, R

    1. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
      A De Luca, D Tricarico, R Wagner, S H Bryant, V Tortorella and D Conte Camerino
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 364-368;

  2. Wahler, G M

    1. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
      M V Westfall, G M Wahler, K Fujino and R J Solaro
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 58-63;

  3. Waite, R P

    1. The sympathetic nervous system facilitates endothelin-1 effects on venous tone.
      R P Waite and C C Pang
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 45-50;

  4. Walsh, R E

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;

  5. Walters, J R

    1. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
      K X Huang and J R Walters
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 409-416;

  6. Wamil, A W

    1. Use-, concentration- and voltage-dependent limitation by MK-801 of action potential firing frequency in mouse central neurons in cell culture.
      A W Wamil and M J McLean
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 376-383;

  7. Weidley, E F

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;

  8. Weinstock, J

    1. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
      R M Edwards, N Aiyar, E H Ohlstein, E F Weidley, E Griffin, M Ezekiel, R M Keenan, R R Ruffolo and J Weinstock
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 175-181;

  9. Welch, S P

    1. A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
      S P Welch, D L Stevens and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 117-127;

  10. Westfall, M V

    1. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
      M V Westfall, G M Wahler, K Fujino and R J Solaro
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 58-63;

  11. Wood, J

    1. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
      U Humke, N Levens, J Wood and K Hofbauer
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 29-35;

Y

  1. Yamada, T

    1. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis.
      T Yamada, K Fujimoto, P Tso, T Fujimoto, T S Gaginella and M B Grisham
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 313-318;

  2. Yang, D C

    1. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
      D Villani-Price, D C Yang, R E Walsh, D J Fretland, R H Keith, G Kocan, J F Kachur, T S Gaginella and B S Tsai
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 187-191;

Z

  1. Zhu, Y

    1. Block of sodium channel current by anticonvulsant U-54494A in mouse neuroblastoma cells.
      Y Zhu and W B Im
      Journal of Pharmacology and Experimental Therapeutics January 1992, 260 (1) 110-116;
Back to top

In this issue